Disclosures for "Safety and Efficacy of Flow-Diverting Stents in Treating Extracranial Internal Carotid Artery Pseudoaneurysms "
-
Dr. Khasawneh has nothing to disclose.
-
Dr. Vellimana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra Inc.
-
Dr. Lu has nothing to disclose.
-
Dr. Shastri has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Chatterjee has nothing to disclose.
-
Dr. Eby has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra Inc..